BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong XL, Wang X, Liu F, Liu X, Du ZR, Li RW, Xue CH, Wong KH, Wong WT, Zhao Q, Tang QJ. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model. Int J Biol Macromol 2020;164:994-1005. [PMID: 32710966 DOI: 10.1016/j.ijbiomac.2020.07.180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Chen R, Yang Z, Wen Q, Cao X, Zhao N, Yan J. Protective Effects of Polysaccharides in Neurodegenerative Diseases. Front Aging Neurosci 2022;14:917629. [DOI: 10.3389/fnagi.2022.917629] [Reference Citation Analysis]
2 Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lu S, Na K, Wei J, Zhang L, Guo X. Alginate oligosaccharides: The structure-function relationships and the directional preparation for application. Carbohydrate Polymers 2022;284:119225. [DOI: 10.1016/j.carbpol.2022.119225] [Reference Citation Analysis]
4 Liu X, Du ZR, Wang X, Sun XR, Zhao Q, Zhao F, Wong WT, Wong KH, Dong X. Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson’s disease. Food Research International 2022;155:111067. [DOI: 10.1016/j.foodres.2022.111067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Gates EJ, Bernath AK, Klegeris A. Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases. Rev Neurosci 2022. [PMID: 35304983 DOI: 10.1515/revneuro-2021-0146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sun Z, Gu P, Xu H, Zhao W, Zhou Y, Zhou L, Zhang Z, Wang W, Han R, Chai X, An S. Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms. Front Cell Dev Biol 2022;9:808905. [DOI: 10.3389/fcell.2021.808905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Vijiaratnam N, Foltynie T. Disease modifying therapies III: Novel targets. Neuropharmacology 2021;201:108839. [PMID: 34656651 DOI: 10.1016/j.neuropharm.2021.108839] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Du ZR, Wang X, Cao X, Liu X, Zhou SN, Zhang H, Yang RL, Wong KH, Tang QJ, Dong XL. Alginate and its Two Components Acted Differently Against Dopaminergic Neuronal Loss in Parkinson's Disease Mice Model. Mol Nutr Food Res 2021;:e2100739. [PMID: 34811884 DOI: 10.1002/mnfr.202100739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 2021;172:105840. [PMID: 34450312 DOI: 10.1016/j.phrs.2021.105840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang C, Franklin CL, Ericsson AC. Consideration of Gut Microbiome in Murine Models of Diseases. Microorganisms 2021;9:1062. [PMID: 34068994 DOI: 10.3390/microorganisms9051062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu X, Du ZR, Wang X, Luk KH, Chan CH, Cao X, Zhao Q, Zhao F, Wong WT, Wong KH, Dong XL. Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson's Disease Mice Model. Front Aging Neurosci 2021;13:649627. [PMID: 33912026 DOI: 10.3389/fnagi.2021.649627] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Lorente-Picón M, Laguna A. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 2021;11:433. [PMID: 33804226 DOI: 10.3390/biom11030433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]